Anders Rosén
Anders Rosén
Correu electrònic verificat a liu.se
Títol
Citada per
Citada per
Any
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro
A Rosén, P Gergely, M Jondal, G Klein, S BRITTON
Nature 267 (5606), 52-54, 1977
4151977
Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic
A Myléus, A Ivarsson, C Webb, L Danielsson, O Hernell, L Högberg, ...
Journal of pediatric gastroenterology and nutrition 49 (2), 170-176, 2009
3162009
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
A Lanemo Myhrinder, E Hellqvist, E Sidorova, A Söderberg, H Baxendale, ...
Blood, The Journal of the American Society of Hematology 111 (7), 3838-3848, 2008
2802008
Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma
A Söderberg, B Sahaf, A Rosén
Cancer research 60 (8), 2281-2289, 2000
1972000
Characterization of a human ovarian teratocarcinoma‐derived cell line
J Zeuthen, JOR Nørgaard, P Avner, M Fellous, J Wartiovaara, A Vaheri, ...
International Journal of Cancer 25 (1), 19-32, 1980
1801980
Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
A König, T Menzel, S Lynen, L Wrazel, A Rosen, A Al-Katib, E Raveche, ...
Leukemia 11 (2), 258-265, 1997
1731997
Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
J Finke, M Rowe, B Kallin, I Ernberg, A Rosen, J Dillner, G Klein
Journal of Virology 61 (12), 3870-3878, 1987
1731987
Target—effector interaction in the natural killer cell system: Isolation of target structures
JC Roder, A Rosén, EM Fenyö, FA Troy
Proceedings of the National Academy of Sciences 76 (3), 1405-1409, 1979
1501979
Secretion of thioredoxin after in vitro activation of human B cells.
ML Ericson, J Hörling, V Wendel-Hansen, A Holmgren, A Rosen
Lymphokine and cytokine research 11 (5), 201-207, 1992
1411992
Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytes.
KA Yamaoka, HE Claesson, A Rosen
The Journal of Immunology 143 (6), 1996-2000, 1989
1311989
Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines
T Noma, T Mizuta, A Rosén, T Hirano, T Kishimoto, T Honjo
Immunology letters 15 (3), 249-253, 1987
1271987
Agarose isoelectric focusing of native human immunoglobulin M and α2-macroglobulin
A Rosén, K Ek, P Åman
Journal of immunological methods 28 (1-2), 1-11, 1979
1211979
Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled …
U Alehagen, P Johansson, M Björnstedt, A Rosén, U Dahlström
International journal of cardiology 167 (5), 1860-1866, 2013
1172013
A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin
A Rosén, P Lundman, M Carlsson, K Bhavani, BR Srinivasa, G Kjellström, ...
International immunology 7 (4), 625-633, 1995
1161995
The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction.
S Paulie, A Rosen, B Ehlin-Henriksson, S Braesch-Andersen, E Jakobson, ...
The Journal of Immunology 142 (2), 590-595, 1989
1161989
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells
B Kallin, J Dillner, I Ernberg, B Ehlin-Henriksson, A Rosén, W Henle, ...
Proceedings of the National Academy of Sciences 83 (5), 1499-1503, 1986
1151986
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
N Cahill, AC Bergh, M Kanduri, H Göransson-Kultima, L Mansouri, ...
Leukemia 27 (1), 150-158, 2013
1132013
Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript
CM Lucas, RJ Harris, A Giannoudis, A Davies, K Knight, SJ Watmough, ...
haematologica 94 (10), 1362-1367, 2009
1132009
Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants
J Romanos, A Rosén, V Kumar, G Trynka, L Franke, A Szperl, ...
Gut 63 (3), 415-422, 2014
1032014
Immunization with glycosylated Kb‐binding peptides generates carbohydrate‐specific, unrestricted cytotoxic T cells
UM Abdel‐Motal, L Berg, A Rosén, M Bengtsson, CJ Thorpe, J Kihlberg, ...
European journal of immunology 26 (3), 544-551, 1996
961996
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20